Green Thumb Industries (GTBIF) Total Non-Current Liabilities (2019 - 2024)
Green Thumb Industries (GTBIF) reported Total Non-Current Liabilities of $747.9 million for Q4 2024, down 0.75% on a YoY basis from $753.6 million in Q1 2024, and up 1.05% quarter-over-quarter from $740.2 million in Q3 2024.
Green Thumb Industries (GTBIF) Total Non-Current Liabilities (2019 - 2024) Analysis & Trends
Green Thumb Industries has reported Total Non-Current Liabilities for 6 years, with the latest figure at $747.9 million in Q4 2024.
- For the quarter ending Q4 2024, Total Non-Current Liabilities fell 0.75% year-over-year to $747.9 million; the trailing twelve-month figure through Dec 2024 stood at $747.9 million (down 0.75% YoY), and the FY2024 full-year result was $747.9 million, down 0.75% from the prior year.
- Total Non-Current Liabilities for Q4 2024 stood at $747.9 million, up from $740.2 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $786.6 million in Q2 2024, with the low at $450291.0 in Q1 2021.
- Historically, Total Non-Current Liabilities has averaged $321.1 million across 5 years, with a median of $1.1 million in 2020.
- Annual changes were most pronounced in 2020 — Total Non-Current Liabilities tumbled 60.51% — and 2023, when it surged 126974.37%.
- Green Thumb Industries' Total Non-Current Liabilities stood at $462000.0 in 2020, then surged by 50.65% to $696000.0 in 2021, then slipped by 14.8% to $593000.0 in 2022, then surged by 126974.37% to $753.6 million in 2023, then retreated by 0.75% to $747.9 million in 2024.
- The last three Total Non-Current Liabilities figures came in at $747.9 million (Q4 2024), $740.2 million (Q3 2024), and $786.6 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 747.93 Mn |
| Sep 30, 2024 | 740.15 Mn |
| Jun 30, 2024 | 786.60 Mn |
| Dec 31, 2023 | 753.55 Mn |
| Sep 30, 2023 | 759.52 Mn |
| Jun 30, 2023 | 775.00 Mn |
| Mar 31, 2023 | 780.75 Mn |
| Dec 31, 2022 | 593,000.00 |
| Sep 30, 2022 | 622,000.00 |
| Jun 30, 2022 | 745.24 Mn |
| Mar 31, 2022 | 672,000.00 |
| Dec 31, 2021 | 696,000.00 |
| Sep 30, 2021 | 720,001.00 |
| Jun 30, 2021 | 4.95 Mn |
| Mar 31, 2021 | 450,291.00 |
| Dec 31, 2020 | 462,000.00 |
| Sep 30, 2020 | 785,724.00 |
| Jun 30, 2020 | 820,888.00 |
| Mar 31, 2020 | 1.13 Mn |
| Dec 31, 2019 | 1.17 Mn |